Engineering surfaces for site-specific vascular differentiation of mouse embryonic stem cells
Source abstract
Abstract
Differentiation of stem and progenitor cells routinely relies on the application of soluble growth factors, an approach that enables temporal control of cell fate but enables no spatial control of the differentiation process. Angiogenic progenitor cells derived from mouse embryonic stem cells (ESCs) were differentiated here according to the pattern of immobilized vascular endothelial growth factor-A (VEGF). Mouse ESCs engineered to express green fluorescent protein (eGFP) under control of promoter for the receptor tyrosine kinase Flk1 were used. The Flk1+ angiogenic progenitors were selected from day 3 differentiating embryoid bodies based on their expression of eGFP using fluorescence activated cell sorting. Mouse VEGF(165) was covalently immobilized onto collagen IV (ColIV) using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) chemistry. A non-cell adhesive layer of photocrosslinkable chitosan was first created, after which VEGF-ColIV was stamped as 100mum wide lanes on top of the chitosan layer and the Flk1+ angiogenic progenitors were seeded for site-specific differentiation. Lanes stamped with only ColIV served as controls. The results presented here demonstrate that the cultivation of Flk1+ progenitors on surfaces with immobilized VEGF yielded primarily endothelial cells (53+/-13% CD31 positive and 17+/-2% smooth muscle actin positive), whereas surfaces without VEGF favored vascular smooth muscle-like cell differentiation (26+/-17% CD31 positive and 38+/-9% smooth muscle actin positive).
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Congenital heart defects research · Electrospun Nanofibers in Biomedical Applications · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Generation of cardiac and endothelial cells from neonatal mouse testis-derived multipotent germline stem cells10.1634/stemcells.2006-0574 ↗
2. Efficiency of embryoid body formation and hematopoietic development from embryonic stem cells in different culture systems10.1002/bit.10220 ↗
3. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse10.1101/gad.1049803 ↗
4. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells10.1016/j.biomaterials.2007.01.021 ↗
5. Multipotent Flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages10.1016/j.devcel.2006.10.002 ↗
6. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification10.1016/j.cell.2006.10.029 ↗
7. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors10.1038/35040568 ↗
8. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation10.1242/dev.00589 ↗
9. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy10.1161/01.CIR.0000123231.49594.21 ↗
10. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation10.1007/s11095-006-9173-4 ↗
11. Engineering vascular networks in porous polymer matrices10.1002/jbm.10134 ↗
12. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth10.1096/fj.02-1041fje ↗
13. Biopolymeric delivery matrices for angiogenic growth factors10.1016/S1054-8807(03)00089-9 ↗
14. Covalently conjugated VEGF–fibrin matrices for endothelialization10.1016/S0168-3659(01)00266-8 ↗
15. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells10.1634/stemcells.2006-0320 ↗
16. A photolithographic method to create cellular micropatterns10.1016/j.biomaterials.2006.04.028 ↗
17. Photocrosslinkable chitosan as a biological adhesive10.1002/(SICI)1097-4636(200002)49:2<289::AID-JBM18>3.0.CO;2-M ↗
18. Photocrosslinkable hydrogel for myocyte cell culture and injection10.1002/jbm.b.30667 ↗
19. Mammalian collagen IV10.1002/jemt.20564 ↗
20. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells10.1016/j.actbio.2007.12.011 ↗
21. Microfluidic patterning for fabrication of contractile cardiac organoids10.1007/s10544-006-9013-7 ↗
22. Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation10.1634/stemcells.2005-0112 ↗
23. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein10.1083/jcb.99.6.2034 ↗
24. Cleavage of structural proteins during the assembly of the head of bacteriophage T410.1038/227680a0 ↗
25. Optical mapping of impulse propagation in engineered cardiac tissue10.1089/ten.tea.2008.0223 ↗
26. Functional immobilization of signaling proteins enables control of stem cell fate10.1038/nmeth.1222 ↗
27. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation10.1242/dev.114.2.521 ↗
28. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain10.1074/jbc.M700319200 ↗
29. Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site10.1073/pnas.94.14.7192 ↗
30. Computer modelling of the receptor-binding domains of VEGF and PIGF10.1093/protein/10.4.389 ↗
31. Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag10.1016/j.biomaterials.2006.06.025 ↗
32. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis10.1016/S0092-8674(00)80283-4 ↗
33. Conditional requirement for the Flk-1 receptor in the in vitro generation of early hematopoietic cells10.1073/pnas.96.13.7370 ↗
34. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death10.1038/35069004 ↗
35. Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors10.1182/blood-2005-05-1970 ↗
36. VEGF-receptor signal transduction10.1016/S0968-0004(03)00193-2 ↗
37. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart10.1016/S1534-5807(03)00363-0 ↗
38. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages10.1016/j.devcel.2006.10.002 ↗
39. Endothelial cells derived from human embryonic stem cells10.1073/pnas.032074999 ↗
40. Bovine aortic endothelial cells display macrophage-like properties towards acetylated 125I-labelled low density lipoprotein10.1016/0005-2760(80)90155-1 ↗
41. Improving arterial prosthesis neo-endothelialization: application of a proactive VEGF construct onto PTFE surfaces10.1016/j.biomaterials.2005.05.051 ↗
42. An extracellular matrix microarray for probing cellular differentiation10.1038/nmeth736 ↗
43. Molecular mechanisms of blood vessel growth10.1016/S0008-6363(00)00281-9 ↗
44. The effect of immobilized platelet derived growth factor AA on neural stem/progenitor cell differentiation on cell-adhesive hydrogels10.1016/j.biomaterials.2008.08.018 ↗
45. Geometric control of stem cell differentiation rate on surfaces10.1021/la802836g ↗
46. Emergence of patterned stem cell differentiation within multicellular structures10.1634/stemcells.2008-0432 ↗
47. Combinatorial protein display for the cell-based screening of biomaterials that direct neural stem cell differentiation10.1016/j.biomaterials.2006.10.004 ↗
48. VEGF-receptor signal transduction10.1016/S0968-0004(03)00193-2 ↗
49. Heterogeneity of endothelial cells. Specific markers10.1161/01.ATV.17.7.1193 ↗
50. Germann · 2005
51. Molecular regulation of vascular smooth muscle cell differentiation in development and disease10.1152/physrev.00041.2003 ↗
52. Diffusion limits of an in vitro thick prevascularized tissue10.1089/ten.2005.11.257 ↗
53. Endothelialized microvasculature based on a biodegradable elastomer10.1089/ten.2005.11.302 ↗
54. Cellular control of tissue architectures using a three-dimensional tissue fabrication technique10.1016/j.biomaterials.2007.08.002 ↗